Biofrontera Inc. Defined Contribution Plan, Cost
Biofrontera Inc. (BFRI) reported Defined Contribution Plan, Cost of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-19
- Biofrontera Inc. defined contribution plan, cost for the quarter ending 2023-12-31 was $100.00K.
- Biofrontera Inc. defined contribution plan, cost for the quarter ending 2023-09-30 was $100.00K, a 0.00% change year-over-year.
- Biofrontera Inc. defined contribution plan, cost for the quarter ending 2023-06-30 was $100.00K, a 0.00% change year-over-year.
- Biofrontera Inc. defined contribution plan, cost for the quarter ending 2023-03-31 was $100.00K, a 0.00% change year-over-year.
- Biofrontera Inc. defined contribution plan, cost for fiscal 2025 was $200.00K, a 0.00% change from fiscal 2024.
- Biofrontera Inc. defined contribution plan, cost for fiscal 2024 was $200.00K, a 33.33% decline from fiscal 2023.
- Biofrontera Inc. defined contribution plan, cost for fiscal 2023 was $300.00K, a 50.00% increase from fiscal 2022.
- Biofrontera Inc. defined contribution plan, cost for fiscal 2022 was $200.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 3 month as first filed | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-19 | ||||
| 2024-12-31 | $200.00K 10-K · filed 2026-03-19 | ||||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $200.00K derived: sum of 2 quarters · filed 2025-03-20 | $300.00K derived: sum of 3 quarters · filed 2025-03-20 | $300.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $200.00K 10-Q · filed 2023-11-09 | $300.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-11 | $200.00K 10-Q · filed 2023-08-11 | $200.00K derived: sum of 3 quarters · filed 2024-03-15 | $300.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2023-03-31 | $100.00K 10-Q · filed 2023-05-12 | $100.00K derived: sum of 2 quarters · filed 2024-03-15 | $200.00K derived: sum of 3 quarters · filed 2024-03-15 | $300.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $100.00K derived: sum of 2 quarters · filed 2024-03-15 | $200.00K derived: sum of 3 quarters · filed 2024-03-15 | $200.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $200.00K 10-Q · filed 2023-11-09 | $300.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-11 | $47.00K 10-Q · filed 2022-08-12 | $100.00K 10-Q · filed 2023-08-11 | $200.00K derived: sum of 3 quarters · filed 2023-10-03 | $300.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-12 | $64.00K 10-Q · filed 2022-05-13 | $100.00K derived: sum of 2 quarters · filed 2023-10-03 | $200.00K derived: sum of 3 quarters · filed 2023-10-03 | $267.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2021-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $100.00K derived: sum of 2 quarters · filed 2023-10-03 | $167.00K derived: sum of 3 quarters · filed 2023-10-03 | $200.00K 8-K · filed 2023-10-03 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $59.00K 10-Q · filed 2021-11-30 | $167.00K derived: sum of 2 quarters · filed 2022-11-14 | $200.00K 10-Q · filed 2022-11-14 | $228.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-12 | $100.00K 10-Q · filed 2022-08-12 | $128.00K derived: sum of 3 quarters · filed 2022-08-12 | $159.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $61.00K 10-Q · filed 2022-05-13 | $61.00K derived: sum of 2 quarters · filed 2022-05-13 | $92.00K derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $31.00K derived: sum of 2 quarters · filed 2022-04-11 | $200.00K 10-K · filed 2022-04-11 | ||
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-30 | $200.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |